v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Revenues:        
Total Revenues $ 49,145 $ 46,724 $ 151,230 $ 129,881
Forwarding Expenses and Cost of Revenues:        
Total Forwarding Expenses and Cost of Revenues 33,035 31,633 103,407 86,822
Gross profit 16,110 15,091 47,823 43,059
Operating Expenses:        
Selling, general and administrative 13,525 13,358 40,576 38,664
Amortization of intangible assets 654 555 1,937 1,635
Total Operating Expenses 14,179 13,913 42,513 40,299
Income from Operations 1,931 1,178 5,310 2,760
Other Items:        
Interest expense (442) (589) (1,668) (1,663)
Other income (loss) (157) (437) 402 (381)
Income Before Income Taxes 1,332 152 4,044 716
Income tax expense (445) (343) (1,058) (412)
Net Income (Loss) 887 (191) 2,986 304
Preferred stock dividends (77) (85) (271) (242)
Non-controlling interest dividends 0 0 (243) 0
Net Income (Loss) Available to Common Stockholders $ 810 $ (276) $ 2,472 $ 62
Net income (loss) per share:        
Basic (in Dollars per share) $ 0.75 $ (0.16) $ 2.52 $ 0.25
Diluted (in Dollars per share) 0.74 (0.16) 2.48 0.25
Net income (loss) per share attributable to common stockholders:        
Basic (in Dollars per share) 0.68 (0.23) 2.08 0.05
Diluted (in Dollars per share) $ 0.67 $ (0.23) $ 2.05 $ 0.05
Weighted average number of shares outstanding:        
Basic (in Shares) 1,186,400 1,186,400 1,186,400 1,186,400
Diluted (in Shares) 1,206,600 1,186,400 1,206,100 1,205,900
Logistics [Member]        
Revenues:        
Total Revenues $ 43,231 $ 40,677 $ 133,361 $ 111,991
Forwarding Expenses and Cost of Revenues:        
Total Forwarding Expenses and Cost of Revenues 31,259 29,725 98,155 81,232
Life Sciences and Manufacturing [Member]        
Revenues:        
Total Revenues 5,914 6,047 17,869 17,890
Forwarding Expenses and Cost of Revenues:        
Total Forwarding Expenses and Cost of Revenues $ 1,776 $ 1,908 $ 5,252 $ 5,590